Matches in SemOpenAlex for { <https://semopenalex.org/work/W2102103650> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W2102103650 endingPage "c68" @default.
- W2102103650 startingPage "c58" @default.
- W2102103650 abstract "Immunoglobulin A nephropathy (IgAN) is one of the most common primary glomerular diseases. Although its clinical course is usually benign, some patients develop end-stage renal failure (ESRF). The role of immunosuppressive drugs in the treatment of IgAN remains controversial. The effect of treatment with prednisolone and azathioprine and the clinical and histological parameters related to a poor outcome are examined retrospectively in this analysis.Seventy-four patients with IgAN and a follow-up period of 10 years were included in this study. Forty-one were treated with prednisolone (initially 60 mg/day) and azathioprine (initially 2 mg/kg BW/day) in gradually reduced doses for 24 +/- 9 months, whereas 33 patients received no immunosuppressive drugs. The clinical course was estimated using the end-points of doubling of baseline serum creatinine and/or ESRF. The contribution of clinical and histological parameters in the clinical outcome was estimated by univariate and multivariate analyses.The overall clinical courses of both groups of patients showed a rather similar pattern. Doubling of serum baseline creatinine was observed in 9 of 41 treated (22%) and in 10 of 33 untreated (30%), whereas ESRF developed in 6 treated (15%) and 6 untreated patients (18%) (p = NS). However, treated patients with heavy proteinuria (>3 g/24 h) had a significantly better outcome compared to untreated (doubling of serum creatinine in 29 vs. 78% and ESRF in 17 vs. 55%, p < 0.05). Proteinuria (p < 0.01), mean blood pressure (p < 0.02), baseline serum creatinine (p = 0.02) and severity of interstitial myofibroblast expression (p = 0.02) were identified as independent risk factors related to a poor outcome by multivariate analysis. Side effects of treatment were not uncommon and observed in 10 (24%) patients.Treatment with prednisolone and azathioprine is beneficial in ameliorating the clinical course of a subset of IgAN patients with heavy proteinuria or impaired renal function. Patients with advanced renal failure and severe chronic histological lesions should not be treated by this regimen as no benefit is expected and there is a risk of side effects." @default.
- W2102103650 created "2016-06-24" @default.
- W2102103650 creator A5018302398 @default.
- W2102103650 creator A5049864091 @default.
- W2102103650 creator A5065012192 @default.
- W2102103650 creator A5066540630 @default.
- W2102103650 creator A5082972319 @default.
- W2102103650 creator A5086154946 @default.
- W2102103650 creator A5087890792 @default.
- W2102103650 date "2004-11-17" @default.
- W2102103650 modified "2023-09-26" @default.
- W2102103650 title "Prednisolone and Azathioprine in IgA Nephropathy" @default.
- W2102103650 cites W2105803357 @default.
- W2102103650 cites W2321910386 @default.
- W2102103650 doi "https://doi.org/10.1159/000068522" @default.
- W2102103650 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12616032" @default.
- W2102103650 hasPublicationYear "2004" @default.
- W2102103650 type Work @default.
- W2102103650 sameAs 2102103650 @default.
- W2102103650 citedByCount "32" @default.
- W2102103650 countsByYear W21021036502012 @default.
- W2102103650 countsByYear W21021036502013 @default.
- W2102103650 countsByYear W21021036502014 @default.
- W2102103650 countsByYear W21021036502015 @default.
- W2102103650 countsByYear W21021036502016 @default.
- W2102103650 countsByYear W21021036502017 @default.
- W2102103650 countsByYear W21021036502021 @default.
- W2102103650 crossrefType "journal-article" @default.
- W2102103650 hasAuthorship W2102103650A5018302398 @default.
- W2102103650 hasAuthorship W2102103650A5049864091 @default.
- W2102103650 hasAuthorship W2102103650A5065012192 @default.
- W2102103650 hasAuthorship W2102103650A5066540630 @default.
- W2102103650 hasAuthorship W2102103650A5082972319 @default.
- W2102103650 hasAuthorship W2102103650A5086154946 @default.
- W2102103650 hasAuthorship W2102103650A5087890792 @default.
- W2102103650 hasConcept C126322002 @default.
- W2102103650 hasConcept C126894567 @default.
- W2102103650 hasConcept C134018914 @default.
- W2102103650 hasConcept C144301174 @default.
- W2102103650 hasConcept C159641895 @default.
- W2102103650 hasConcept C2775919214 @default.
- W2102103650 hasConcept C2776715498 @default.
- W2102103650 hasConcept C2776760755 @default.
- W2102103650 hasConcept C2779134260 @default.
- W2102103650 hasConcept C2779561371 @default.
- W2102103650 hasConcept C2780091579 @default.
- W2102103650 hasConcept C2780306776 @default.
- W2102103650 hasConcept C2781184683 @default.
- W2102103650 hasConcept C38180746 @default.
- W2102103650 hasConcept C555293320 @default.
- W2102103650 hasConcept C71924100 @default.
- W2102103650 hasConcept C90924648 @default.
- W2102103650 hasConceptScore W2102103650C126322002 @default.
- W2102103650 hasConceptScore W2102103650C126894567 @default.
- W2102103650 hasConceptScore W2102103650C134018914 @default.
- W2102103650 hasConceptScore W2102103650C144301174 @default.
- W2102103650 hasConceptScore W2102103650C159641895 @default.
- W2102103650 hasConceptScore W2102103650C2775919214 @default.
- W2102103650 hasConceptScore W2102103650C2776715498 @default.
- W2102103650 hasConceptScore W2102103650C2776760755 @default.
- W2102103650 hasConceptScore W2102103650C2779134260 @default.
- W2102103650 hasConceptScore W2102103650C2779561371 @default.
- W2102103650 hasConceptScore W2102103650C2780091579 @default.
- W2102103650 hasConceptScore W2102103650C2780306776 @default.
- W2102103650 hasConceptScore W2102103650C2781184683 @default.
- W2102103650 hasConceptScore W2102103650C38180746 @default.
- W2102103650 hasConceptScore W2102103650C555293320 @default.
- W2102103650 hasConceptScore W2102103650C71924100 @default.
- W2102103650 hasConceptScore W2102103650C90924648 @default.
- W2102103650 hasIssue "2" @default.
- W2102103650 hasLocation W21021036501 @default.
- W2102103650 hasLocation W21021036502 @default.
- W2102103650 hasOpenAccess W2102103650 @default.
- W2102103650 hasPrimaryLocation W21021036501 @default.
- W2102103650 hasRelatedWork W2013701055 @default.
- W2102103650 hasRelatedWork W2031694281 @default.
- W2102103650 hasRelatedWork W2057561566 @default.
- W2102103650 hasRelatedWork W2102103650 @default.
- W2102103650 hasRelatedWork W2127053900 @default.
- W2102103650 hasRelatedWork W2800811471 @default.
- W2102103650 hasRelatedWork W2916219914 @default.
- W2102103650 hasRelatedWork W4235119269 @default.
- W2102103650 hasRelatedWork W4241625063 @default.
- W2102103650 hasRelatedWork W593504957 @default.
- W2102103650 hasVolume "93" @default.
- W2102103650 isParatext "false" @default.
- W2102103650 isRetracted "false" @default.
- W2102103650 magId "2102103650" @default.
- W2102103650 workType "article" @default.